表紙
市場調查報告書

局部止痛藥的全球市場:2028年

Global Topical Pain Relief Market Outlook 2028

出版商 Research Nester 商品編碼 940301
出版日期 內容資訊 英文 175 Pages
商品交期: 最快1-2個工作天內
價格
局部止痛藥的全球市場:2028年 Global Topical Pain Relief Market Outlook 2028
出版日期: 2020年05月01日內容資訊: 英文 175 Pages
簡介

類鴉片物質止痛藥、非類鴉片物質止痛藥所構成的全球局部止痛藥的市場,預計在預測期間內將以4.31%的年複合成長率發展。主要製藥企業和政府機關的R&D活動的投資擴大,老年人增加,骨關節炎和自體免疫性關節炎等肌肉骨骼系統疾病的盛行率增加,疼痛管理用經皮吸收貼片的開發相關技術的進步等要素預計促進該市場的成長。還有運動員之間的局部、經皮藥膏,貼片受歡迎,對關節炎,尤其是骨關節炎的興趣高漲等要素預計也帶動今後的市場成長。

本報告提供全球局部止痛藥的市場調查,市場及產品概要,相關法律、專利、臨床試驗、開發平台分析,市場成長的各種影響因素分析,市場規模的變化、預測,治療等級、類型、劑型等各種區分的明細,各主要地區、國家的詳細分析,主要企業簡介等資訊彙整。

第1章 簡介

第2章 前提條件、簡稱

第3章 調查手法

第4章 摘要整理

第5章 法規情形

第6章 專利分析

第7章 臨床試驗分析

第8章 開發平台分析

第9章 市場動態

  • 促進因素
  • 阻礙因素
  • 趨勢
  • 市場機會

第10章 風險分析

  • 需求風險分析
  • 供給風險分析

第11章 全球局部止痛藥市場展望

  • 市場規模、預測
    • 各治療等級
    • 各類型
    • 各劑型
    • 各銷售管道
    • 各地區

第12章 北美的局部止痛藥市場展望

  • 宏觀經濟指標
  • 市場規模、預測
    • 各治療等級
    • 各類型
    • 各劑型
    • 各銷售管道
    • 各國

第13章 歐洲的局部止痛藥市場展望

  • 宏觀經濟指標
  • 市場規模、預測
    • 各治療等級
    • 各類型
    • 各劑型
    • 各銷售管道
    • 各國

第14章 亞太地區的局部止痛藥市場展望

  • 宏觀經濟指標
  • 市場規模、預測
    • 各治療等級
    • 各類型
    • 各劑型
    • 各銷售管道
    • 各國

第15章 南美的局部止痛藥市場展望

  • 宏觀經濟指標
  • 市場規模、預測
    • 各治療等級
    • 各類型
    • 各劑型
    • 各銷售管道
    • 各國

第16章 中東、非洲的局部止痛藥市場展望

  • 宏觀經濟指標
  • 市場規模、預測
    • 各治療等級
    • 各類型
    • 各劑型
    • 各銷售管道
    • 各國

第17章 競爭情形

  • Topical BioMedics
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceutical Industries Ltd.
  • AdvaCare Pharma
  • Teikoku Pharma USA, Inc.
  • Sanofi
  • Johnson and Johnson
  • Novartis
  • Pfizer Inc.
  • GlaxoSmithKline plc

第18章 策略性建議

目錄

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

Topical pain relief market comprises of opioid and non-opioid analgesics that are offered as creams, foams, gels, lotions, ointments and others. These analgesics are applied to body surfaces such as the skin or mucous membranes to treat painful ailments. Topical pain relief offers high concentrations of drug in peripheral effector sites, as opposed to the low serum levels of those sites on the back of which undesirable side effects are much lower on topical analgesic application. The global topical pain relief market is anticipated to achieve a CAGR of 4.31% over the forecast period, i.e. 2021-2028. Factors such as increasing investments from leading pharmaceutical companies as well as government organizations for R&D activities, increasing elderly population, growing prevalence of musculoskeletal disorders, such as osteoarthritis and autoimmune arthritis along with the growing technological advancements pertaining to the development of transdermal patches for pain management are anticipated to contribute significantly towards the growth of the global topical pain relief market. Additionally, growing popularity of topical as well as transdermal creams and patches among the sportspersons and the growing concern for arthritis, especially osteoarthritis are some of the factors anticipated to drive the growth of the global topical pain relief market.

The global topical pain relief market consists of various segments that are segmented by therapeutic class, formulation, distribution channel and by region. The formulation segment is further sub-divided into cream & rubs, patch, spray, gel and others. Out of these, the cream & rubs segment held a value of USD 2521.95 million in the year 2019 and is anticipated to reach a value of USD 3581.22 million by the end of 2028 by growing at a CAGR of 4.10% over the forecast period.

Based on region, the global topical pain relief market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Asia Pacific, which had accounted for 20.21% share in the year 2019, is estimated to witness the highest CAGR of 5.02% over the forecast period and cross a value of USD 2392.52 by the end of 2028.

Some of the affluent industry leaders in the global topical pain relief market are: Reckitt Benckiser Group plc, Teikoku Pharma USA, Inc., Topical BioMedics, Inc., Sun Pharmaceutical Industries Ltd., AdvaCare Pharma®, Sanofi, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc. and GlaxoSmithKline plc.

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Assumptions and Abbreviations

3. Research Methodology

  • 3.1. Research Process
  • 3.2. Secondary Research
  • 3.3. Primary Research
  • 3.4. Market Size Estimation

4. Executive Summary - Global Topical Pain Relief Market

5. Regulatory Landscape

6. Patent Analysis

7. Clinical Trial Analysis

8. Pipeline Analysis

9. Market Dynamics

  • 9.1. Drivers
  • 9.2. Restraints
  • 9.3. Trends
  • 9.4. Opportunities

10. Topical Pain Relief Market - Risk Analysis

  • 10.1. Demand Risk Analysis
  • 10.2. Supply Risk Analysis

11. Global Topical Pain Relief Market Outlook

  • 11.1. Market Size and Forecast, 2018-2027F - By Value (USD Million)
    • 11.1.1. By Therapeutic Class, 2019-2028F (USD MILLION)
      • 11.1.1.1. Non-Opioids, 2019-2028F (USD MILLION)
        • 11.1.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
        • 11.1.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
        • 11.1.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
        • 11.1.1.1.1.3. Others, 2019-2028F (USD MILLION)
        • 11.1.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
        • 11.1.1.1.3. Others, 2019-2028F (USD MILLION)
      • 11.1.1.2. Opioids, 2019-2028F (USD MILLION)
    • 11.1.2. By Type, 2019-2028F (USD MILLION)
      • 11.1.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
      • 11.1.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
    • 11.1.3. By Formulation, 2019-2028F (USD MILLION)
      • 11.1.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
      • 11.1.3.2. Patch, 2019-2028F (USD MILLION)
      • 11.1.3.3. Spray, 2019-2028F (USD MILLION)
      • 11.1.3.4. Gel, 2019-2028F (USD MILLION)
      • 11.1.3.5. Others, 2019-2028F (USD MILLION)
    • 11.1.4. By Distribution Channel, 2019-2028F (USD MILLION)
      • 11.1.4.1. Online, 2019-2028F (USD MILLION)
      • 11.1.4.2. Offline, 2019-2028F (USD MILLION)
        • 11.1.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
        • 11.1.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
        • 11.1.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
        • 11.1.4.2.4. Others, 2019-2028F (USD MILLION)
    • 11.1.5. By Region
      • 11.1.5.1. North America, Europe, Asia Pacific, Latin America, Middle East & Africa

12. North America Topical Pain Relief Market Outlook

  • 12.1. Macro-Economic Indicators impacting the North America Topical Pain Relief Market
  • 12.2. Market Size & Forecast (USD Million)
    • 12.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
      • 12.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
        • 12.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
        • 12.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
        • 12.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
        • 12.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
        • 12.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
        • 12.2.1.1.3. Others, 2019-2028F (USD MILLION)
      • 12.2.1.2. Opioids, 2019-2028F (USD MILLION)
    • 12.2.2. By Type, 2019-2028F (USD MILLION)
      • 12.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
      • 12.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
    • 12.2.3. By Formulation, 2019-2028F (USD MILLION)
      • 12.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
      • 12.2.3.2. Patch, 2019-2028F (USD MILLION)
      • 12.2.3.3. Spray, 2019-2028F (USD MILLION)
      • 12.2.3.4. Gel, 2019-2028F (USD MILLION)
      • 12.2.3.5. Others, 2019-2028F (USD MILLION)
    • 12.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
      • 12.2.4.1. Online, 2019-2028F (USD MILLION)
      • 12.2.4.2. Offline, 2019-2028F (USD MILLION)
        • 12.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
        • 12.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
        • 12.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
        • 12.2.4.2.4. Others, 2019-2028F (USD MILLION)
    • 12.2.5. By Country, 2019-2028F (USD MILLION)
      • 12.2.5.1. US, 2019-2028F (USD MILLION)
      • 12.2.5.2. Canada, 2019-2028F (USD MILLION)

13. Europe Topical Pain Relief Market Outlook

  • 13.1. Macro-Economic Indicators impacting the Europe Topical Pain Relief Market
  • 13.2. Market Size & Forecast (USD Million)
    • 13.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
      • 13.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
        • 13.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
        • 13.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
        • 13.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
        • 13.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
        • 13.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
        • 13.2.1.1.3. Others, 2019-2028F (USD MILLION)
      • 13.2.1.2. Opioids, 2019-2028F (USD MILLION)
    • 13.2.2. By Type, 2019-2028F (USD MILLION)
      • 13.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
      • 13.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
    • 13.2.3. By Formulation, 2019-2028F (USD MILLION)
      • 13.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
      • 13.2.3.2. Patch, 2019-2028F (USD MILLION)
      • 13.2.3.3. Spray, 2019-2028F (USD MILLION)
      • 13.2.3.4. Gel, 2019-2028F (USD MILLION)
      • 13.2.3.5. Others, 2019-2028F (USD MILLION)
    • 13.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
      • 13.2.4.1. Online, 2019-2028F (USD MILLION)
      • 13.2.4.2. Offline, 2019-2028F (USD MILLION)
        • 13.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
        • 13.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
        • 13.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
        • 13.2.4.2.4. Others, 2019-2028F (USD MILLION)
    • 13.2.5. By Country, 2019-2028F (USD MILLION)
      • 13.2.5.1. UK, 2019-2028F (USD MILLION)
      • 13.2.5.2. Germany, 2019-2028F (USD MILLION)
      • 13.2.5.3. Italy, 2019-2028F (USD MILLION)
      • 13.2.5.4. France, 2019-2028F (USD MILLION)
      • 13.2.5.5. Spain, 2019-2028F (USD MILLION)
      • 13.2.5.6. Turkey, 2019-2028F (USD MILLION)
      • 13.2.5.7. Russia, 2019-2028F (USD MILLION)
      • 13.2.5.8. Rest of Europe, 2019-2028F (USD MILLION)

14. Asia Pacific Topical Pain Relief Market Outlook

  • 14.1. Macro-Economic Indicators impacting the Asia Pacific Topical Pain Relief Market
  • 14.2. Market Size & Forecast (USD Million)
    • 14.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
      • 14.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
        • 14.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
        • 14.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
        • 14.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
        • 14.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
        • 14.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
        • 14.2.1.1.3. Others, 2019-2028F (USD MILLION)
      • 14.2.1.2. Opioids, 2019-2028F (USD MILLION)
    • 14.2.2. By Type, 2019-2028F (USD MILLION)
      • 14.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
      • 14.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
    • 14.2.3. By Formulation, 2019-2028F (USD MILLION)
      • 14.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
      • 14.2.3.2. Patch, 2019-2028F (USD MILLION)
      • 14.2.3.3. Spray, 2019-2028F (USD MILLION)
      • 14.2.3.4. Gel, 2019-2028F (USD MILLION)
      • 14.2.3.5. Others, 2019-2028F (USD MILLION)
    • 14.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
      • 14.2.4.1. Online, 2019-2028F (USD MILLION)
      • 14.2.4.2. Offline, 2019-2028F (USD MILLION)
        • 14.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
        • 14.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
        • 14.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
        • 14.2.4.2.4. Others, 2019-2028F (USD MILLION)
    • 14.2.5. By Country, 2019-2028F (USD MILLION)
      • 14.2.5.1. China, 2019-2028F (USD MILLION)
      • 14.2.5.2. India, 2019-2028F (USD MILLION)
      • 14.2.5.3. Japan, 2019-2028F (USD MILLION)
      • 14.2.5.4. South Korea, 2019-2028F (USD MILLION)
      • 14.2.5.5. Australia, 2019-2028F (USD MILLION)
      • 14.2.5.6. Rest of Asia Pacific, 2019-2028F (USD MILLION)

15. Latin America Topical Pain Relief Market Outlook

  • 15.1. Macro-Economic Indicators impacting the Latin America Topical Pain Relief Market
  • 15.2. Market Size & Forecast (USD Million)
    • 15.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
      • 15.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
        • 15.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
        • 15.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
        • 15.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
        • 15.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
        • 15.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
        • 15.2.1.1.3. Others, 2019-2028F (USD MILLION)
      • 15.2.1.2. Opioids, 2019-2028F (USD MILLION)
    • 15.2.2. By Type, 2019-2028F (USD MILLION)
      • 15.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
      • 15.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
    • 15.2.3. By Formulation, 2019-2028F (USD MILLION)
      • 15.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
      • 15.2.3.2. Patch, 2019-2028F (USD MILLION)
      • 15.2.3.3. Spray, 2019-2028F (USD MILLION)
      • 15.2.3.4. Gel, 2019-2028F (USD MILLION)
      • 15.2.3.5. Others, 2019-2028F (USD MILLION)
    • 15.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
      • 15.2.4.1. Online, 2019-2028F (USD MILLION)
      • 15.2.4.2. Offline, 2019-2028F (USD MILLION)
        • 15.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
        • 15.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
        • 15.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
        • 15.2.4.2.4. Others, 2019-2028F (USD MILLION)
    • 15.2.5. By Country, 2019-2028F (USD MILLION)
      • 15.2.5.1. Brazil, 2019-2028F (USD MILLION)
      • 15.2.5.2. Mexico, 2019-2028F (USD MILLION)
      • 15.2.5.3. Rest of Latin America, 2019-2028F (USD MILLION)

16. Middle East & Africa Topical Pain Relief Market Outlook

  • 16.1. Macro-Economic Indicators impacting the Middle East & Africa Topical Pain Relief Market
  • 16.2. Market Size & Forecast (USD Million)
    • 16.2.1. By Therapeutic Class, 2019-2028F (USD MILLION)
      • 16.2.1.1. Non-Opioids, 2019-2028F (USD MILLION)
        • 16.2.1.1.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS), 2019-2028F (USD MILLION)
        • 16.2.1.1.1.1. Capsaicin, 2019-2028F (USD MILLION)
        • 16.2.1.1.1.2. Methyl Salicylates, 2019-2028F (USD MILLION)
        • 16.2.1.1.1.3. Others, 2019-2028F (USD MILLION)
        • 16.2.1.1.2. Lidocaine, 2019-2028F (USD MILLION)
        • 16.2.1.1.3. Others, 2019-2028F (USD MILLION)
      • 16.2.1.2. Opioids, 2019-2028F (USD MILLION)
    • 16.2.2. By Type, 2019-2028F (USD MILLION)
      • 16.2.2.1. Prescription Pain Relief, 2019-2028F (USD MILLION)
      • 16.2.2.2. Over-the-counter Pain Relief, 2019-2028F (USD MILLION)
    • 16.2.3. By Formulation, 2019-2028F (USD MILLION)
      • 16.2.3.1. Cream & Rubs, 2019-2028F (USD MILLION)
      • 16.2.3.2. Patch, 2019-2028F (USD MILLION)
      • 16.2.3.3. Spray, 2019-2028F (USD MILLION)
      • 16.2.3.4. Gel, 2019-2028F (USD MILLION)
      • 16.2.3.5. Others, 2019-2028F (USD MILLION)
    • 16.2.4. By Distribution Channel, 2019-2028F (USD MILLION)
      • 16.2.4.1. Online, 2019-2028F (USD MILLION)
      • 16.2.4.2. Offline, 2019-2028F (USD MILLION)
        • 16.2.4.2.1. Pharmacies, 2019-2028F (USD MILLION)
        • 16.2.4.2.2. Retail Stores, 2019-2028F (USD MILLION)
        • 16.2.4.2.3. Hypermarkets/Supermarkets, 2019-2028F (USD MILLION)
        • 16.2.4.2.4. Others, 2019-2028F (USD MILLION)
    • 16.2.5. By Country, 2019-2028F (USD MILLION)
      • 16.2.5.1. Israel, 2019-2028F (USD MILLION)
      • 16.2.5.2. Saudi Arabia, 2019-2028F (USD MILLION)
      • 16.2.5.3. UAE, 2019-2028F (USD MILLION)
      • 16.2.5.4. South Africa, 2019-2028F (USD MILLION)
      • 16.2.5.5. Rest of Middle East & Africa, 2019-2028F (USD MILLION)

17. Competitive Landscape

  • Topical BioMedics
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceutical Industries Ltd.
  • AdvaCare Pharma
  • Teikoku Pharma USA, Inc.
  • Sanofi
  • Johnson and Johnson
  • Novartis
  • Pfizer Inc.
  • GlaxoSmithKline plc

18. Strategic Recommendations